<DOC>
	<DOCNO>NCT01910077</DOCNO>
	<brief_summary>The purpose study demonstrate bioequivalence tacrobell capsule 1mg prograf capsule 1mg .</brief_summary>
	<brief_title>Bioequivalence Study Tacrobell Capsule 1mg Prograf Capsule 1mg</brief_title>
	<detailed_description>This open label , randomize , single dose , 2-treatment , 2-period crossover study healthy volunteers.Study treatment administer fasting condition . Blood sample analysis tacrolimus blood obtain follow : Predose ( immediately prior dose ) , 0.25 , 0.5 , 0.75 , 1 , 1.25 , 1.5 , 1.75 , 2 , 3 , 4 , 6 , 8 , 12 , 24 , 48 , 72 96 hour postdose .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Signed informed consent prior screen test Between 19 year 55 year healthy male subject Have congenital chronic disease medical symptom Body mass index ( BMI ) 18 30 total body weight â‰¥ 55kg Appropriate subject study judge investigator Evidence history clinically significant hepatic , renal , neurologic , immune system , respiratory system , endocrine Any condition possibly affect drug absorption ( e.g . gastrectomy ) Subject hypersensitivity tacrolimus excipient Administration cyclosporin bosentan Administration potassiumsparing diuretic Subject hereditary disease galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption SBP &lt; 90 mmHg DBP &lt; 50 mmHg , SBP &gt; 150 mmHg DBP &gt; 100 mmHg least 3 minute rest A positive HBsAg , HCV Ab , HIV Ab , RPR AST , ALT &gt; 1.5*upper limit normal range screen test Subject history drug abuse positive reaction drug abuse screen test Taking ETC medicine include oriental medicine within 14days first hospitalization take OTC medicine , vitamin within 7days Use drug know significantly induce inhibit drugmetabolizing enzyme within 30 day prior initiation test Participating bioequivalence study clinical study within 3 month precede first hospitalization Blood donation within 2 month component blood donation within 1 month prior first hospitalization Continued drinking ( alcohol &gt; 21 units/week , 1 unit=10g pure alcohol ) clinical trial drink Severe heavy smoker ( cigarette &gt; 10 cigarettes/day ) 3 month smoke clinical study Continued take caffeine take caffeine Continued take grapefruit take grapefruit Not use contraception clinical study An impossible one participate clinical trial investigator 's decision include reason laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>tacrolimus</keyword>
	<keyword>tacrobell capsule</keyword>
	<keyword>prograf capsule</keyword>
	<keyword>bioequivalence</keyword>
</DOC>